Treatment of Chronic Myelomonocytic Leukemia with 5-Azacytidine: Case Reports

Epigenetic therapy with hypomethylating agent (5-azacytidine; AZA) is common in the management of specific subtypes of myelodysplastic syndrome (MDS), but there are only few studies in chronic myelomonocytic leukemia (CMML) patients. In this paper our experience with 3 CMML patients treated with AZA...

Full description

Saved in:
Bibliographic Details
Main Authors: Rohon, Peter, Vondrakova, Jana, Jonasova, Anna, Holzerova, Milena, Jarosova, Marie, Indrak, Karel
Format: Artigo
Language:Inglês
Published: Hindawi Publishing Corporation 2012
Subjects:
Case Report
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3420792/
https://ncbi.nlm.nih.gov/pubmed/22937326
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2012/369086
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items